QIMR Berghofer Medical Research Institute
Professor Mark Smyth (FAA, FAHMS) is a Senior Scientist and Immunology Coordinator at QIMR Berghofer Medical Research Institute. He completed his PhD in 1988 and trained at the NCI (1988-1992), before commencing his independent research career in Australia. Over the last 20 years he rekindled world-wide interest in cancer immune surveillance, defined immune-mediated dormancy of cancer, and the role of the host immunity in chemotherapy and targeted therapy responses. More recently, he has provided new means of classifying natural killer cell (NK) subtypes and three new targets for cancer immunotherapy. He is a past winner of the William Coley Medal and Charles Brupbacher Foundation Prizes in Cancer Research. He has a number of scientific research agreements, consultancies, new patents and other patents licenced to industry. He has an H-Index of 144, is the highest cited immunologist in Australia, and is a Senior Editor, and Advisory Board Member for Cancer Immunology Research and Science, respectively.